GangaGen Engineered therapeutic protein antibiotics targeting drug-resistant Enterobacteriaceae
IATI Identifier: US-EIN-04-2103547-GangaGen
Published on
- date_range Aug 01, 2020 - Jun 30, 2024
- autorenew Implementation (Status)
- mail Contact
- share Share
TBD
more_horiz
Sectors:
-
Infectious disease control
Participating Organisations
| Name | Type | Role |
|---|---|---|
| GangaGen Biotechnologies Pvt Ltd | Funding | |
| GangaGen | Private Sector | Implementing |
Transaction
| Transaction Value |
Provider
Receiver |
Type | Date |
|---|---|---|---|
| 500,665 USD (Valued at Jan 25, 2024) | Provider N/A Receiver N/A | Expenditure |
date_range
Jan 25, 2024
|
| 205,061 USD (Valued at Aug 31, 2023) | Provider N/A Receiver N/A | Expenditure |
date_range
Jun 08, 2023
|
Budget
705,726
USD
-
500,665 USD (Valued at Jan 24, 2024)date_range Jun 08, 2023 - Jun 30, 2023
-
205,061 USD (Valued at Jan 24, 2024)date_range Jul 01, 2022 - Jul 31, 2022
access_time
Updated on
Jan 25, 2024 22:36:13